Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
Abstract Background The tumour–stroma ratio (TSR) is identified as a promising prognostic parameter for breast cancer, but the cutoff TSR value is mostly assessed by visual assessment, which lacks objective measurement. The aims of this study were to optimize the cutoff TSR value, and evaluate its p...
Main Authors: | Dandan Yan, Xianli Ju, Bin Luo, Feng Guan, Huihua He, Honglin Yan, Jingping Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-10183-5 |
Similar Items
-
Significance of Tumor–Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors
by: Jung-Soo Pyo, et al.
Published: (2023-07-01) -
Does tumor stroma ratio of breast cancer trucut biopsy determine response to neoadjuvant therapy?
by: Varuna Mallya, et al.
Published: (2020-01-01) -
The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma
by: Lamia Sabry ABOELNASR, et al.
Published: (2023-01-01) -
Tumor–stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma
by: Dong Wang, et al.
Published: (2023-05-01) -
The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma
by: Mei Lu, et al.
Published: (2023-07-01)